Endocannabinoid signalling in the regulation of hypothalamic-pituitary neuroendocrine circuits: A review
By: Anabela Nagyova and Natasa Hlavacova
References
- Atwood BK, Mackie K. CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160, 467–479, 2010.
- Benowitz NL, Jones RT, Lerner CB. Depression of growth hormone and cortisol response to insulin-induced hypoglycemia after prolonged oral delta-9-tetrahydrocannabinol administration in man. J Clin Endocrinol Metab 42, 938–941, 1976.
- Bakos J, Srancikova A, Havranek T, Bacova Z. Molecular mechanisms of oxytocin signaling at the synaptic connection. Neural Plast 2018, 4864107, 2018.
- Bonnet U. Chronic cannabis abuse, delta-9-tetrahydrocannabinol and thyroid function. Pharmacopsychiatry 46, 35–36, 2013.
- Borie AM, Young LJ, Liu RC. Sex-specific and social experience-dependent oxytocin-endocannabinoid interactions in the nucleus accumbens: implications for social behaviour. Philos Trans R Soc Lond B Biol Sci 377, 20210057, 2022.
- Childs E, Lutz JA, de Wit H. Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress. Drug Alcohol Depend 177, 136–144, 2017.
- Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grübler Y, Stalla J, Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function. Endocrinology 148, 1574–1581, 2007.
- Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterisation of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384, 83–87, 1996.
- da Veiga MA, Fonseca Bloise F, Costa-E-Sousa RH, Souza LL, Almeida NA, Oliveira KJ, Pazos-Moura CC. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist AM251 in the regulation of thyrotropin secretion. J Endocrinol 199, 235–242, 2008.
- Dalterio SL, Michael SD, Macmillan BT, Bartke A. Differential effects of cannabinoid exposure and stress on plasma prolactin, growth hormone and corticosterone levels in male mice. Life Sci 28, 761–766, 1981.
- Deli L, Wittmann G, Kallo I, Lechan RM, Watanabe M, Liposits Z, Fekete C. Type 1 cannabinoid receptor-containing axons innervate hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons. Endocrinology 150, 98–103, 2009.
- Di S, Malcher-Lopes R, Halmos KC, Tasker JG. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23, 4850–4857, 2003.
- Di Marzo V, Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: “Killing two birds with one stone.” Prostaglandins Leukot Essent Fatty Acids 53, 1–11, 1995.
- Di Marzo V, Bifulco M, De Petrocellis L. The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3, 771–784, 2004.
- Dlugos A, Childs E, Stuhr KL, Hillard CJ, de Wit H. Acute stress increases circulating anandamide and other N-acylethanolamines in healthy humans. Neuropsychopharmacology 37, 2416–2427, 2012.
- Evanson NK, Tasker JG, Hill MN, Hillard CJ, Herman JP. Fast feedback inhibition of the HPA axis by glucocorticoids is mediated by endocannabinoid signaling. Endocrinology 151, 4811–4819, 2010.
- Falkenstein BA, Holley DC. Effect of acute intravenous administration of delta-9-tetrahydrocannabinol on the episodic secretion of immunoassayable growth hormone in the rat. Life Sci 50, 1109–1116, 1992.
- Farkas I, Kallo I, Deli L, Vida B, Hrabovszky E, Fekete C, Moenter SM, Watanabe M, Liposits Z. Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 151, 5818–5829, 2010.
- Forner-Piquer I, Giommi C, Sella F, Lombo M, Montik N, Dalla Valle L, Carnevali O. Endocannabinoid system and metabolism: the influences of sex. Int J Mol Sci 25, 11909, 2024.
- Gaoni Y, Mechoulam R. Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86, 1646–1647, 1964.
- Gorzalka BB, Dang SS. Minireview: Endocannabinoids and gonadal hormones: bidirectional interactions in physiology and behavior. Endocrinology 153, 1016–1024, 2012.
- Gowatch LC, Evanski JM, Ely SL, Zundel CG, Bhogal A, Carpenter C, Shampine MM, O’Mara E, Mazurka R, Barcelona J, Mayo LM, Marusak HA. Endocannabinoids and stress-related neuropsychiatric disorders: a systematic review and meta-analysis of basal concentrations and response to acute psychosocial stress. Cannabis Cannabinoid Res 9, 1217–1234, 2024.
- Gundersen TD, Jorgensen N, Andersson AM, Bang AK, Nordkap L, Skakkebak NE, Priskorn L, Juul A, Jensen TK. Association between use of marijuana and male reproductive hormones and semen quality. Am J Epidemiol 182, 473–481, 2015.
- Harris C, Weiss GL, Di S, Tasker JG. Cell signaling dependence of rapid glucocorticoid-induced endocannabinoid synthesis in hypothalamic neuroendocrine cells. Neurobiol Stress 10, 100158, 2019.
- Hebert-Chatelain E, Desprez T, Serrat R, Bellocchio L, Soria-Gomez E, Busquets-Garcia A, Pagano Zottola AC, Delamarre A, Cannich A, Vincent P, Varilh M, Robin LM, Terral G, Garcia-Fernandez MD, Colavita M, Mazier W, Drago F, Puente N, Reguero L, Elezgarai I, Dupuy JW, Cota D, Lopez-Rodriguez ML, Barreda-Gomez G, Massa F, Grandes P, Benard G, Marsicano G. A cannabinoid link between mitochondria and memory. Nature 539, 555–559, 2016.
- Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka BB. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the HPA axis. Neuropsychopharmacology 34, 2733–2745, 2009.
- Hill MN, Tasker JG. Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis. Neuroscience 204, 5–16, 2012.
- Hillard CJ, Farber NE, Hagen TC, Bloom AS. The effects of delta 9-tetrahydrocannabinol on serum thyrotropin levels in the rat. Pharmacol Biochem Behav 20, 547–550, 1984.
- Hillard CJ. Endocannabinoids and the endocrine system in health and disease. Handb Exp Pharmacol 231, 317–339, 2015.
- Hirasawa M, Schwab Y, Natah S, Hillard CJ, Mackie K, Sharkey KA, Pittman QJ. Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J Physiol 559, 611–624, 2004.
- Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie, K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54, 161–202, 2002.
- Hughes CL Jr, Everett JW, Tyrey L. Delta 9-tetrahydrocannabinol suppression of prolactin secretion in the rat: lack of direct pituitary effect. Endocrinology 109, 876–880, 1981.
- Kano M. Control of synaptic function by endocannabinoid-mediated retrograde signaling. Proc Jpn Acad Ser B 90, 235–250, 2014.
- Kalak P, Kupczyk P, Szumny A, Gebarowski T, Jasiak M, Niedzwiedz A, Nizanski W, Dziecioł M. Molecular mechanisms of the endocannabinoid system with a focus on reproductive physiology and fertility. Int J Mol Sci 26, 7095, 2025.
- Katona I, Sperlagh B, Sík A, Kafalvi A, Vizi ES, Mackie K, Freund TF. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544–4558, 1999.
- Kleinloog D, Liem-Moolenaar M, Jacobs G, Klaassen E, De Kam M, Hijman R, Van Gerven J. Does olanzapine inhibit the psychomimetic effects of THC? J Psychopharmacol 26, 1307–1316, 2012.
- Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-White J, Liposits Z, Kunos G, Grossman AB, Fekete C, Korbonits M. The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS One 3, e1797, 2008.
- Kozak KR, Crews BC, Morrow JD, Wang LH, Ma YH, Weinander R, Jakobsson PJ, Marnett LJ. Metabolism of endocannabinoids into prostaglandin derivatives. J Biol Chem 277, 44877–44885, 2002.
- Liem-Moolenaar M, Te Beek ET, De Kam ML, Franson KL, Kahn RS, Hijman R, Touw D, Van Gerven JM. CNS effects of haloperidol on THC. J Psychopharmacol 24, 1697–1708, 2010.
- Luce V, Solari JF, Rettori V, De Laurentiis A. The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide. Regul Pept 188, 31–39, 2014.
- Marino M, D’Auria R, Mele E, Pastorino GMG, Di Pietro P, D’Angelo S, Della Rocca N, Operto FF, Vecchione C, Fasano S, Pierantoni R, Viggiano A, Meccariello R, Santoro A. The interplay between kisspeptin and endocannabinoid systems modulates male hypothalamic and gonadic control of reproduction in vivo. Front Endocrinol 14, 1269334, 2023.
- Marsicano G, Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur J Neurosci 11, 4213–4225, 1999.
- Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor. Nature 346, 561–564, 1990.
- Mendelson JH, Mello NK. Effects of marijuana on neuroendocrine hormones. NIDA Res Monogr 44, 97–114, 1984.
- Micale V, Drago F. Endocannabinoid system, stress and HPA axis. Eur J Pharmacol 834, 230–239, 2018.
- Miralpeix C, Reguera AC, Fosch A, Zagmutt S, Casals N, Cota D, Rodriguez-Rodriguez R. Hypothalamic endocannabinoids in obesity. Cell Mol Life Sci 78, 7469–7490, 2021.
- Morena M, Patel S, Bains JS, Hill MN. Interactions between stress and the endocannabinoid system. Neuropsycho-pharmacology 41, 80–102, 2016.
- Munro S, Thomas KL, Abu-Shaar M. Peripheral receptor for cannabinoids. Nature 365, 61–65, 1993.
- Murphy LL, Steger RW, Smith MS, Bartke A. Effects of cannabinoids on LH and prolactin. Neuroendocrinology 52, 316–321, 1990.
- Nagyova A, Jezova D, Hlavacova N. Inhibition of fatty acid amide hydrolase (FAAH) by URB597 counteracts cognitive deficit and alters neuroendocrine stress responses in male and female rats. bioRxiv 2025.12.20.695675, 2025.
- Nazar B, Kairys DJ, Fowler R, Harclerode J. Effects of THC on thyroxine. J Pharm Pharmacol 29, 778–779, 1977.
- O’Sullivan SE. PPAR activation by cannabinoids. Br J Pharmacol 173, 1899–1910, 2016.
- Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. Endocannabinoid system in endocrine regulation. Endocr Rev 27, 73–100, 2006.
- Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid modulation of HPA axis. Endocrinology 145, 5431–5438, 2004.
- Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW. Cannabis and male fertility. J Urol 202, 674–681, 2019.
- Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuro-pharmacology 54, 108–116, 2008.
- Ranganathan M, Braley G, Pittman B, Cooper T, Perry E, Krystal J, D’souza DC. Effects of cannabinoids on cortisol and prolactin. Psychopharmacology 203, 737–744, 2009.
- Rettori V, Wenger T, Snyder G, Dalterio S, McCann SM. THC inhibits prolactin and GH release. Neuroendocrinology 47, 498–503, 1988.
- Rettori V, Aguila MC, Gimeno MF, Franchi AM, McCann SM. In vitro effect of delta 9-tetrahydrocannabinol to stimulate somatostatin release and block that of luteinizing hormone-releasing hormone by suppression of the release of prostaglandin E2. Proc Natl Acad Sci USA 87, 10063–10066, 1990.
- Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. GPR55 as cannabinoid receptor. Br J Pharmacol 152, 1092–1101, 2007.
- Scorticati C, Mohn C, De Laurentiis A, Vissio P, Fernandez Solari J, Seilicovich A, McCann SM, Rettori V. Anandamide effect on prolactin. Proc Natl Acad Sci USA 100, 2134–2139, 2003.
- Simon GM, Cravatt BF. Endocannabinoid biosynthesis pathway. J Biol Chem 281, 26465–26472, 2006.
- Suarez J, Romero-Zerbo SY, Rivera P, Bermudez-Silva FJ, Perez J, De Fonseca FR, Fernandez-Llebrez P. Endocannabinoid system in rat brain. J Comp Neurol 518, 3065–3085, 2010.
- Tasker JG, Chen C, Fisher MO, Fu X, Rainville JR, Weiss GL. Endocannabinoid regulation of neuroendocrine systems. Int Rev Neurobiol 125, 163–201, 2015.
- Tretiakov EO, Hevesi Z, Boroczky C, Alpar A, Harkany T, Keimpema E. Molecular fingerprint of endocannabinoid signaling. Cells 14, 788, 2025.
- Vilela FC, Giusti-Paiva A. Cannabinoid receptor agonist disrupts responses during lactation. Behav Brain Res 263, 190–197, 2014.
- Wilson RI, Nicoll RA. Endogenous cannabinoids mediate retrograde signalling. Nature 410, 588–592, 2001.
- Wittmann G, Deli L, Kallo I, Hrabovszky E, Watanabe M, Liposits Z, Fekete C. Distribution of CB1 receptor axons. J Comp Neurol 503, 270–279, 2007.
- Ziegler CG, Mohn C, Lamounier-Zepter V, Rettori V, Bornstein SR, Krug AW, Ehrhart-Bornstein M. Expression and function of endocannabinoid receptors in the human adrenal cortex. Horm Metab Res 42, 88–92, 2010.
- Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, Julius D, Hogestatt ED. Vanilloid receptors mediate vasodilation. Nature 400, 452–457, 1999.
Language: English
Page range: 98 - 110
Published on: Jun 27, 2026
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Anabela Nagyova, Natasa Hlavacova, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.